TruSpine Technologies Plc

Management Reports • Oct 25, 2023

National Storage Mechanism | Additional information

RNS Number : 2455R

TruSpine Technologies PLC

25 October 2023

25 October 2023

TruSpine Technologies plc

("TruSpine" or the "Company")

IP Registration

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems announces that it has, with the help of the Company's newly appointed IP lawyers, published the original assignment of the Intellectual Property Rights to the Company as per the Original IP Agreement and Addendum.

The patents acquired as part of the Intellectual Property Rights can be viewed at the following link: 

https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignee?assigneeName=TRUSPINE%20TECHNOLOGIES%20LIMITED

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's admission document dated 19 August 2020.

TruSpine CEO Laurence Strauss commented: "I am delighted to report  that the IP of the Company is held in the name of TruSpine Technologies PLC and can be viewed on the IP website link provided in this announcement. Our thanks go to the team at McCarter & English, LLP for their work in concluding this matter.

"On a personal level, I am pleased that with this matter resolved, the management team can now fully focus on developing the portfolio. In this regard I look forward to reporting on further progress with our FDA 510(k) application for Cervi-LOK."

Enquiries:

TruSpine Technologies Plc	Tel: +44 (0)20 7118 0852
Laurence Strauss, Chief Executive Officer
Cairn Financial Advisers LLP (AQSE Corporate Adviser)	Tel: +44 (0)20 7213 0880
Liam Murray / Ludovico Lazzaretti
Peterhouse Capital Limited (Broker & Financial Adviser)	Tel: +44 (0)20 7469 0930
Lucy Williams / Duncan Vasey
Novus Communications (PR and IR)	Tel: +44 (0)20 7448 9839
Alan Green / Jacqueline Briscoe	[email protected]

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXDELBLXBLXFBQ